Detalhe da pesquisa
1.
Editorial: How Will Aducanumab Approval Impact AD Research?
J Prev Alzheimers Dis;
8(4): 391-392, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34585209
2.
Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions.
Acta Neuropathol Commun;
9(1): 128, 2021 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289895
3.
Pathological drivers of neurodegeneration in suspected non-Alzheimer's disease pathophysiology.
Alzheimers Res Ther;
13(1): 100, 2021 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990226
4.
Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
Neuropathol Appl Neurobiol;
46(7): 707-721, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32892355
5.
Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis.
Acta Neuropathol Commun;
6(1): 84, 2018 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30157956
6.
Connexin-43 and aquaporin-4 are markers of ageing-related tau astrogliopathy (ARTAG)-related astroglial response.
Neuropathol Appl Neurobiol;
44(5): 491-505, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28755467
7.
Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
Neuropathol Appl Neurobiol;
43(7): 604-620, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28386933
8.
Comparison of In Vivo and Ex Vivo MRI of the Human Hippocampal Formation in the Same Subjects.
Cereb Cortex;
27(11): 5185-5196, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664967
9.
Progression of alpha-synuclein pathology in multiple system atrophy of the cerebellar type.
Neuropathol Appl Neurobiol;
43(4): 315-329, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27716988
10.
FASTKD2 is associated with memory and hippocampal structure in older adults.
Mol Psychiatry;
20(10): 1197-204, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25385369
11.
Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.
Transl Psychiatry;
4: e419, 2014 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25072324
12.
CSF protein biomarkers predicting longitudinal reduction of CSF ß-amyloid42 in cognitively healthy elders.
Transl Psychiatry;
3: e293, 2013 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23962923
13.
Alterations in metabolic pathways and networks in Alzheimer's disease.
Transl Psychiatry;
3: e244, 2013 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-23571809
14.
Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment.
Psychol Med;
43(5): 911-20, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22954311
15.
Plasma biomarkers of depressive symptoms in older adults.
Transl Psychiatry;
2: e65, 2012 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22832727
16.
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.
Neurology;
77(23): 2034-42, 2011 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22131541
17.
On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.
Prog Neurobiol;
95(4): 649-62, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21911035
18.
Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies.
Curr Top Med Chem;
11(3): 317-30, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21320060
19.
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.
Neurology;
76(1): 69-79, 2011 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-21123754
20.
TDP-43 pathology occurs infrequently in multiple system atrophy.
Neuropathol Appl Neurobiol;
37(4): 358-65, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20942898